Sirius XM heads into its May 28 Q1 results with analysts moving in the same direction for the first time in months, while shorts — still carrying a meaningful position — have been slowly covering since mid-April.
The most notable development this week came from the Street. Every analyst action since late April has been a target raise, and the direction of travel is unmistakeable. Rosenblatt made the boldest move in late April, upgrading to Buy from Neutral and lifting its target to $46 — nearly double its prior $24 — though that target looks aggressive relative to the cluster of other estimates. More representative of the broader shift: JPMorgan raised its target to $26 from $24 while keeping a Neutral rating, Evercore ISI moved to $28 from $24, Guggenheim to $34 from $29, and Barrington Research to $32 from $28. Citigroup is the outlier — it raised its target too, to $22 from $19, but kept a Sell rating, keeping a ceiling on the consensus mean of roughly $28. The consensus return potential against the $26.40 close is modest at around 6%, but the directional shift in targets post-earnings is the meaningful signal here.
Options positioning is tilted toward calls rather than puts — more constructive than usual. The put/call ratio has dropped to 0.47, notably below its 20-day average of 0.53 and roughly 1.2 standard deviations below that mean. The 52-week high on the PCR was 0.64, hit in early April when the broader market was selling off. Since then, as SIRI has clawed back 11% over the past month and 0.5% over the past week, options traders have shifted meaningfully toward calls. That said, cost to borrow is barely a consideration — running at just 0.46% annualised — and borrow availability is wide open, with the lending pool nowhere near tight. Availability is running well above normal relative to the 52-week high utilization of 62.6%, suggesting no squeeze dynamic is building in the borrowing market.
Short interest itself adds an interesting wrinkle. At roughly 9.9% of the free float, the position is not trivial, but the trend is clearly lower. Shorts peaked above 31 million shares in mid-April around the time the market sold off hardest, and have since trimmed back to approximately 30.2 million — a steady two-week grind of covering that coincides almost exactly with the analyst upgrade cycle. The ORTEX short score sits at 62.2, near the middle of the recent range, and the factor score ranks SI in just the 11th percentile relative to its own history — meaning the current level is not extreme by the stock's own standards. Days to cover of around 4.7 days, per the screening data, underlines that any unwinding of the short position would not be disruptive.
Berkshire Hathaway remains the ownership story that looms over everything else here. As the largest holder at 37% of shares outstanding, and with a string of open-market purchases in July and August of last year at prices in the $21-$22 range, Buffett's position anchors the stock. Gregory Maffei, the former Liberty Media executive, added 2.5 million shares earlier this year. John Malone trimmed modestly in early April. Insider activity from management has been limited and mostly routine. The ownership structure means a large portion of the float is effectively locked up, which in turn shapes how the short interest statistics read — 9.9% of the free float is a more constrained number than it might appear against total shares outstanding.
The bear case is structural: EV adoption erodes the automotive distribution moat over time, streaming alternatives are cheap and proliferating, and free cash flow generation has been under pressure. The bull case rests on the strength of the existing subscriber base, the content moat around exclusive talk and sports programming, and a valuation that at 7.2x EV/EBITDA and a P/E of 8.3 is not demanding. The 12-month forward yield of 4.3% provides a carry cushion for patient holders.
With Q1 results due May 28, the next read on subscriber trends and cash flow guidance is the data point worth watching — particularly whether the recent improvement in EPS estimate momentum, which ranks in the 53rd percentile on a 90-day basis, is beginning to build into a more consistent upward revision cycle.
See the live data behind this article on ORTEX.
Open SIRI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
